Tags

Type your tag names separated by a space and hit enter

[Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV].
Antibiot Khimioter. 2011; 56(7-8):42-6.AK

Abstract

Foreign experience with empirical management of severe acute respiratory syndrome (SARS) due to coronavirus, genotype IV is described. It is indicated that the data on the efficacy of ribavirin with respect to SARS in the patients are contradictory. The efficacy of two chemotherapeutics, i. e. lopinavir and ritonavir used in the SARS foci is confirmed. The drugs are at present applicable all over the world in retrovirus therapy of HIV infected subjects. The search for efficient Russian unspecific medicines for control of SARS is actual.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

rus

PubMed ID

22359870

Citation

Shchukina, V N., et al. "[Experience With Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IV]." Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [sic], vol. 56, no. 7-8, 2011, pp. 42-6.
Shchukina VN, Loginova SIa, Borisevich SV, et al. [Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV]. Antibiot Khimioter. 2011;56(7-8):42-6.
Shchukina, V. N., Loginova, S. I. a., Borisevich, S. V., & Bondarev, V. P. (2011). [Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV]. Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [sic], 56(7-8), 42-6.
Shchukina VN, et al. [Experience With Empirical Treatment of Severe Acute Respiratory Syndrome Due to Coronavirus, Genotype IV]. Antibiot Khimioter. 2011;56(7-8):42-6. PubMed PMID: 22359870.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV]. AU - Shchukina,V N, AU - Loginova,S Ia, AU - Borisevich,S V, AU - Bondarev,V P, PY - 2012/2/25/entrez PY - 2012/3/1/pubmed PY - 2012/3/27/medline SP - 42 EP - 6 JF - Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] JO - Antibiot Khimioter VL - 56 IS - 7-8 N2 - Foreign experience with empirical management of severe acute respiratory syndrome (SARS) due to coronavirus, genotype IV is described. It is indicated that the data on the efficacy of ribavirin with respect to SARS in the patients are contradictory. The efficacy of two chemotherapeutics, i. e. lopinavir and ritonavir used in the SARS foci is confirmed. The drugs are at present applicable all over the world in retrovirus therapy of HIV infected subjects. The search for efficient Russian unspecific medicines for control of SARS is actual. SN - 0235-2990 UR - https://www.unboundmedicine.com/medline/citation/22359870/[Experience_with_empirical_treatment_of_severe_acute_respiratory_syndrome_due_to_coronavirus_genotype_IV]_ DB - PRIME DP - Unbound Medicine ER -